Appointment of Denis Tebbutt a charmhealth trifecta

09 July 2014

Australia’s leading developer and supplier of specialist oncology electronic medical record and clinical information systems, charmhealth, today announced the appointment of Denis Tebbutt to its Board of Directors.

Tebbutt joins healthcare IT industry veterans Bryan Wrighton (also a Director) and Gary Lakin (recently appointed as CEO) to complete the team that will lead charmhealth as it grows its core oncology business and expands into new markets.

“charmhealth is an example of the leadership that Australian technology companies can achieve when focused on this critical sector of our healthcare industry, reducing the suffering and financial impact that cancer has for all Australians.  I am pleased to be part of a Board that is focused on having a greater impact in this sector for all stakeholders,” said Tebbutt.

Tebbutt’s recent career has focused on meeting the challenges of the Australian healthcare sector including as Managing Director of iSOFT and InterSystems and recently as the industry advisor to NeHTA.  He is currently a Board Member of the Health Informatics Society of Australia (HISA). He is widely acknowledged as an expert in healthcare IT and as having the capability to transform businesses and drive growth with improved margins.

He has held a number of board positions in technology, retail and marketing based companies and advised venture capital funds on their portfolio companies.  Prior to entering the healthcare sector Tebbutt held senior executive roles within international software companies across three continents with solutions for the manufacturing and financial services industries.

Anne-Marie Birkill, charmhealth Chair, commented: “I am delighted Denis has agreed to join charmhealth bringing tremendous, expertise, experience and networks to the existing charmhealth Team. His passion for catalysing change in the healthcare sector that impacts positively on the patient experience will be a key driver for charmhealth moving forward.”

charmhealth is a portfolio company of the OneVentures Innovation Fund.

For more information, contact:

Gary Lakin

charmhealth Chief Executive Officer

Mobile: +61 (0) 400 808 504

Email: [email protected]

Anne-Marie Birkill

OneVentures General Partner and charmhealth Chair of the Board

Mobile: +61 (0) 419 789 401

Email:[email protected]

About charmhealth

charmhealth develops, delivers and supports state-of-the-art software solutions to manage the many functions of Oncology Facilities in private and public hospital settings.

To date over 40 such facilities, supporting more than 45,000 patients annually, are licensed to use Charm software, including the Peter Macallum Cancer Centre, Queensland Health, ACT Health and Cabrini Health.

charmhealth is currently developing its next generation product, CharmNG. CharmNG expands the extensive functional capabilities of its current generation CHARM product and provides a range of deployment options from traditional on premise to a fully hosted offering. CharmNG provides an advanced platform for charmhealth to move beyond the oncology market to service other chronic care sectors.

charmhealth solutions mitigate compliance, clinical, financial and administrative risk by ensuring the most up to date patient information is available to all healthcare providers, in real time, when making important clinical and prescribing decisions.

Read more about charmhealth at

About OneVentures:

OneVentures is a venture capital firm that invests in emerging Australian technology companies with true breakout potential, differentiated technology and compelling business models in the clean technology, information technology and life sciences sectors.

OneVentures is managed by a team of partners with a skills set and track record ideally suited to collaboration with entrepreneurial management teams to foster growth and create value: a unique blend of highly successful entrepreneurs, technology business founders and corporate executives with a strong scientific pedigree, extensive off-shore experience and networks.

The OneVentures Innovation Fund is a $40 million venture capital fund formed as an Early Stage Venture Capital Limited Partnership. OneVentures is supported by the Australian Government through the IIF program with this funding matched by institutional investors, individual high net worth investors and family offices. The IIF is an Australian Government venture capital initiative that provides investment capital and managerial expertise through licensed venture capital fund managers to investee companies.

Read more about OneVentures at

Learn More

You may also like

04 September 2017

Citadel Group aquires OneVentures portfolio company Charm Health

18 July 2016

DoseMe partners with Charm Health to improve management of high risk oncology medicines and deliver “precision medicine” to Australian cancer patients

19 April 2016

Icon Group signs up Charm Health to support cancer care

24 March 2014

charmhealth names Gary Lakin as new CEO

View All

Ventured. Gained.

Subscribe to our Newsletter.

decor decor decor
decor decor decor decor decor